Both in Pharmaceuticals
Eledon Pharmaceuticals vs Keros Therapeutics
Over the past year ELDN returned −35.1% and KROS returned −30.4%; their daily moves had a correlation of 0.13.
ELDN −35.1% KROS −30.4%Growth of $1, one year, split-adjusted
| Metric | ELDN | KROS |
|---|---|---|
| Price | $2.70 | $10.83 |
| Market cap | $219.4M | $214.7M |
| Today | +3.05% | 0.00% |
| 1 month | +10.2% | −1.6% |
| 6 months | −28.9% | −8.1% |
| Year to date | +78.8% | −46.8% |
| 1 year | −38.1% | −28.8% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 14.3× |
| Net cash | $88.8M | $257.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.6% | 43.2% |
| Short % of float | 9.7% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).